Recent prostate cancer single-cell and spatial transcriptomic analyses (e.g., by Han Lin and colleagues) classified CAFs into iCAF, myCAF, and apCAF states, and identified C11_HLA-DRA as a representative apCAF cluster. Here, HLA-DRA is linked to prostate carcinoma.